Atezolizumab Monotherapy as First-line Treatment in Patients with Advanced BRAF V600 Wild-type Melanoma
Journal of Clinical Haematology(2021)
Abstract
Juliano C. Coelho1,2*, Taiane F. Rebelatto1,2, Rodrigo R. Pereira1,2,3, Pedro E. R. Liedke1,2,3, Andrea B. Zanon1, Sergio J. Azevedo1,2,3 1Unidade de Pesquisa Clínica em Oncologia, Porto Alegre, Brazil 2Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil 3Department of Oncology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil *Correspondence should be addressed to Juliano C. Coelho; juliano.oncologia@gmail.com
MoreTranslated text
Key words
monotherapy,advanced brafv600,treatment,first-line,wild-type
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined